Clinical Trial Update: Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries [Phase 2]

View source ↗

Summary

A Phase 2 trial testing autologous incubated macrophages for complete spinal cord injury has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous Incubated Macrophages

Snippet

Sponsor: Proneuron Biotechnologies | Conditions: Spinal Cord Injury | Phase 2 | Status: SUSPENDED